Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03713281 · ClinicalTrials.gov registry record

Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population

A clinical trial of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
30
Enrollment target
1
Study location

NCT03713281 is a study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 30 participants, below the 139-participant average among 20 other Visual Acuity trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03713281, a study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The study is a bilateral, single-masked, single-arm, 3-visit dispensing study. There will be one study treatment, with the subject being in the treatment for approximately 12-16 days.

Conditions Studied

Interventions

  • DEVICE Toric Multifocal etafilcon A with PVP

Study Locations (1)

Tennessee

  • Total Eye Care PA - Memphis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-10-04
Est. Completion 2019-02-19

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT03713281

The ClinicalTrials.gov registry entry for NCT03713281 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 20 other Visual Acuity trials with a reported enrollment target (78% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 1 intervention - of which Toric Multifocal etafilcon A with PVP is the first listed.

NCT03713281 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03713281 about?

NCT03713281 is a clinical study titled "Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population". The study is a bilateral, single-masked, single-arm, 3-visit dispensing study. There will be one study treatment, with the subject being in the treatment for approximately 12-16 days.

What is the current status of trial NCT03713281?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-10-04. Estimated completion is 2019-02-19.

What conditions does trial NCT03713281 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT03713281?

The interventions under investigation include: Toric Multifocal etafilcon A with PVP (DEVICE).

Who is sponsoring clinical trial NCT03713281?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03713281 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.